Bayforest Capital Ltd increased its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 188.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,098 shares of the company's stock after purchasing an additional 13,790 shares during the period. Bayforest Capital Ltd's holdings in Oscar Health were worth $452,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the company. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Oscar Health by 15.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,862 shares of the company's stock worth $186,000 after purchasing an additional 1,834 shares during the last quarter. GAMMA Investing LLC lifted its position in Oscar Health by 2,156.4% during the 1st quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock valued at $85,000 after purchasing an additional 6,189 shares during the period. Prosperity Wealth Management Inc. boosted its stake in shares of Oscar Health by 10.6% in the 1st quarter. Prosperity Wealth Management Inc. now owns 87,676 shares of the company's stock valued at $1,149,000 after purchasing an additional 8,399 shares during the last quarter. Finally, Oppenheimer & Co. Inc. boosted its stake in shares of Oscar Health by 4.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock valued at $372,000 after purchasing an additional 1,250 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.
Analyst Upgrades and Downgrades
OSCR has been the topic of several analyst reports. Raymond James Financial lowered shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. UBS Group reissued a "sell" rating and issued a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. The Goldman Sachs Group started coverage on Oscar Health in a research note on Tuesday. They set a "neutral" rating and a $17.00 price objective for the company. Robert W. Baird reissued a "neutral" rating and issued a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Oscar Health in a report on Wednesday, October 8th. Five research analysts have rated the stock with a Hold rating and six have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Strong Sell" and an average target price of $13.19.
Read Our Latest Stock Analysis on Oscar Health
Oscar Health Stock Performance
Shares of Oscar Health stock opened at $20.80 on Wednesday. The stock's fifty day simple moving average is $18.04 and its 200 day simple moving average is $15.96. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $5.38 billion, a PE ratio of -25.68 and a beta of 1.89. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.20 earnings per share. On average, research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.
Insider Transactions at Oscar Health
In other news, insider Mario Schlosser sold 395,000 shares of the company's stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the transaction, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 25.11% of the company's stock.
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
